Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125839201 | 12583920 | 1 | I | 201212 | 20121226 | 20160722 | 20160722 | EXP | US-BIOGEN-2012BI064919 | BIOGEN | 43.87 | YR | F | Y | 0.00000 | 20160722 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125839201 | 12583920 | 1 | PS | AVONEX | INTERFERON BETA-1A | 1 | Intramuscular | P41035 | 103628 | 30 | UG | SOLN FOR INJECT IN PRE-FILLED SYRINGE | /wk | ||||||
| 125839201 | 12583920 | 2 | SS | AVONEX | INTERFERON BETA-1A | 1 | Intramuscular | P41035 | 103628 | 30 | UG | SOLN FOR INJECT IN PRE-FILLED SYRINGE | /wk | ||||||
| 125839201 | 12583920 | 3 | SS | AVONEX | INTERFERON BETA-1A | 1 | Intramuscular | P41035 | 103628 | 30 | UG | SOLN FOR INJECT IN PRE-FILLED SYRINGE | /wk | ||||||
| 125839201 | 12583920 | 4 | SS | AVONEX | INTERFERON BETA-1A | 1 | Intramuscular | P41035 | 103628 | 30 | UG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | /wk | ||||||
| 125839201 | 12583920 | 5 | C | Glucozide (NOS) | 2 | Oral | 0 | 2.5 | MG | TABLETS | QD | ||||||||
| 125839201 | 12583920 | 6 | C | JANUVIA | SITAGLIPTIN PHOSPHATE | 1 | Oral | 0 | 50 | MG | TABLETS | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125839201 | 12583920 | 1 | Multiple sclerosis |
| 125839201 | 12583920 | 5 | Diabetes mellitus |
| 125839201 | 12583920 | 6 | Diabetes mellitus |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125839201 | 12583920 | HO |
| 125839201 | 12583920 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125839201 | 12583920 | Anaesthetic complication | |
| 125839201 | 12583920 | Arthralgia | |
| 125839201 | 12583920 | Balance disorder | |
| 125839201 | 12583920 | Fall | |
| 125839201 | 12583920 | Femur fracture | |
| 125839201 | 12583920 | Gait disturbance | |
| 125839201 | 12583920 | Hemiparesis | |
| 125839201 | 12583920 | Hip fracture | |
| 125839201 | 12583920 | Memory impairment | |
| 125839201 | 12583920 | Mobility decreased | |
| 125839201 | 12583920 | Multiple sclerosis | |
| 125839201 | 12583920 | Muscular weakness | |
| 125839201 | 12583920 | Pain |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125839201 | 12583920 | 1 | 19970701 | 0 | ||
| 125839201 | 12583920 | 2 | 20121207 | 20130201 | 0 | |
| 125839201 | 12583920 | 3 | 20130622 | 0 | ||
| 125839201 | 12583920 | 4 | 20130623 | 0 | ||
| 125839201 | 12583920 | 5 | 1989 | 0 | ||
| 125839201 | 12583920 | 6 | 2007 | 0 |